Genpact LTD DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
Genpact issues a supplement to its proxy statement to address concerns raised by Glass Lewis regarding the disclosure of racial/ethnic minority demographic information about its director nominees.
NYSE
Genpact Limited has filed a definitive proxy statement with the U.S. Securities and Exchange Commission.
NYSE
Genpact exceeded expectations in 2024 with strong financial results and is prioritizing innovation with new AI offerings in 2025.
NYSE
Genpact clarifies the circumstances surrounding a former executive's departure and equity award vesting in response to an ISS recommendation against the Say-on-Pay proposal.
NYSE
Genpact Limited has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
Genpact's 2024 proxy statement highlights a solid financial performance in 2023, driven by digital operations and Data-Tech-AI services, with a strategic focus on strengthening its foundation for future growth through AI integration and leadership development.